| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 5,250 |
| Contractor | Explanation |
|---|---|
| DCF Capital | MANAGEMENT FEES |
| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CNECN 8.000000% 06/30/2015 - 2 | ||
| US TREASURY BILL 0% 12/10/2015 | 2,993,910 | 2,999,777 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CELLDEX THERAPEUT INC-1000 SHS | 5,494 | 3,150 |
| CELLDEX THERAPEUT INC-1000 SHS | 4,259 | 3,150 |
| CELLDEX THERAPEUT INC-1500 SHS | 6,760 | 4,725 |
| CELLDEX THERAPEUT INC-1500 SHS | 5,726 | 4,725 |
| CELLDEX THERAPEUT INC-700 SHS | 3,898 | 2,205 |
| CELLDEX THERAPEUT INC-2000 SHS | 9,790 | 6,300 |
| CELLDEX THERAPEUT INC-2000 SHS | 10,489 | 6,300 |
| CELLDEX THERAPEUT INC-3500 SHS | 17,247 | 11,025 |
| ELI LILLY & CO - 200 SHS | 14,530 | 14,768 |
| INCYTE CORP - 3700 SHS | 30,255 | 321,789 |
| ELI LILLY & CO - 50 SHS | 4,375 | 3,692 |
| SERES THERAPEUT INC - 100 SHS | 2,854 | 1,079 |
| SERES THERAPEUT INC - 100 SHS | 2,598 | 1,079 |
| SERES THERAPEUT INC - 600 SHS | 6,448 | 6,474 |
| ELI LILLY & CO - 100 SHS | 7,314 | 7,384 |
| SHIRE PLC-ADR - 100 SHS | 19,604 | 16,864 |
| ITCI INC - 500 SHS | 7,513 | 6,200 |
| ITCI INC - 1000 SHS | 17,039 | 12,400 |
| ITCI INC - 1000 SHS | 19,528 | 12,400 |
| ITCI INC - 500 SHS | 8,257 | 6,200 |
| ITCI INC - 400 SHS | 6,120 | 4,960 |
| ITCI INC - 100 SHS | 1,704 | 1,240 |
| SANGAMO BIO INC - 1000 SHS | 5,638 | 3,550 |
| TRILLIUM THERA INC - 400 SHS | 5,302 | 5,460 |
| TRILLIUM THERA INC - 500 SHS | 6,754 | 6,825 |
| PHARMACEUTICALS - 100 SHS | 13,568 | 34,502 |
| SHIRE PLC-ADR - 200 SHS | 41,140 | 33,728 |
| SANGAMO BIOSCIENC INC-1000 SHS | 5,308 | 3,550 |
| TRILLIUM THERA INC - 100 SHS | 1,319 | 1,365 |
| SERES THERA INC - 100 SHS | 1,083 | 1,079 |
| SERES THERA INC - 200 SHS | 6,802 | 2,158 |
| NEKTAR THERAPEUTICS - 3000 SHS | 36,750 | 37,200 |
| NEKTAR THERAPEUTICS - 500 SHS | 6,463 | 6,200 |
| ASTRAZENECA PLC - 500 SHS | 17,259 | 14,160 |
| ASTRAZENECA PLC - 500 SHS | 14,900 | 14,160 |
| ANADARKO PET CORP - 100 SHS | 6,285 | 5,944 |
| ALIMERA SCIENCE INC - 1000 SHS | 3,058 | 1,250 |
| FIBROGEN INC - 500 SHS | 9,316 | 8,275 |
| ACADIA PHARM INC - 200 SHS | 5,375 | 4,662 |
| ACADIA PHARM INC - 500 SHS | 15,868 | 11,655 |
| ITCI - 500 SHS | 12,503 | 6,200 |
| ACADIA PHARM INC - 500 SHS | 15,874 | 11,655 |
| ALIMERA SCI INC - 1000 SHS | 3,195 | 1,250 |
| ALIMERA SCI INC - 1000 SHS | 1,596 | 1,250 |
| ALIMERA SCI INC - 1000 SHS | 1,661 | 1,250 |
| ALDER BIO INC - 1000 SHS | 25,156 | 24,250 |
| ACADIA PHARM INC - 500 SHS | 16,704 | 11,655 |
| ALDER BIO INCE - 100 SHS | 2,425 | 2,425 |
| ALDER BIO INC - 200 SHS | 5,709 | 4,850 |
| ITCI INC - 300 SHS | 8,745 | 3,720 |
| ITCI INC - 500 SHS | 7,645 | 6,200 |
| ITCI INC - 1000 SHS | 17,948 | 12,400 |
| NEKTAR THERAPEUTICS - 1000 SHS | 10,131 | 12,400 |
| PSIVIDA - 1000 SHS | 4,320 | 2,080 |
| ELI LILLY & CO - 200 SHS | 17,213 | 14,768 |
| ELI LILLY & CO - 300 SHS | 0 | |
| NEKTAR THERAPEUTICS - 1000 SHS | 11,069 | 12,400 |
| NEKTAR THERAPEUTICS - 1000 SHS | 10,786 | 12,400 |
| AMARIN CORPORATION - 5000 SHS | 5,529 | 15,600 |
| ITCI - 700 SHS | 20,699 | 8,680 |
| CELLDEX THERAPEUTICS - 1000 SH | 10,842 | 3,150 |
| AMARIN CORPORATION - 2000 SHS | 2,100 | 6,240 |
| INCYTE CORP - 200 SHS | 0 | |
| AMARIN CORPORATION - 3000 SHS | 3,030 | 9,360 |
| NEKTAR THERAPEUTICS - 500 SHS | 0 | |
| DOW CHEMICAL - 1000 SHS | 0 | |
| GW PHARMACEUTICALS - 200 SHS | 14,420 | 23,478 |
| ABBVIE INC - 500 SHS | 0 | |
| ALLEGRAN PLC - 100 SHS | 0 | |
| ALLEGRAN PLC - 100 SHS | 0 | |
| FORD MOTOR CO - 2000 SHS | 0 | |
| FORD MOTOR CO - 3000 SHS | 0 | |
| XLY - 400 SHS | 0 | |
| DOW CHEMICAL - 1000 SHS | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| JEFFERIES - SERVICE CHARGES | 10 | 10 |
| Description | Amount |
|---|---|
| PRIOR PERIOD ADJUSTMENT | 638 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| SHORT POSITIONS |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PORTFOLIO MANAGEMENT FEES | 44,788 | 44,788 |
| Item No. | 1 |
|---|---|
| Borrower's Name | LOAN TO DOUG FLOREN |
| Borrower's Title | |
| Original Amount of Loan | 2500 |
| Balance Due | |
| Date of Note | |
| Maturity Date | |
| Repayment Terms | |
| Interest Rate | |
| Security Provided by Borrower | |
| Purpose of Loan | |
| Description of Lender Consideration | |
| Consideration FMV |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAX | 1,384 | |||
| PENALTY | 30 |